Back to Directory

Michael McKenna

Email

michael.8.mckenna@gsk.com

Phone

44 7557 290 283

Institution

GSK

Address

GlaxoSmithKline
Stockley Park West
1-3 Ironbridge Road
Uxbridge
Middlesex
UB11 1BT
,
United Kingdom

Request an Update

Affiliated Studies

IMPAACT 2029: Phase I/II Study of Switching to Fixed Dose Combination Dolutegravir/Rilpivirine among Virologically Suppressed Children and Adolescents Living with HIV

DAIDS Number

Research Area

Study Status

IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

DAIDS Number

Research Area

Study Status

Closed to Accrual